A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative Colitis
Public ClinicalTrials.gov record NCT02589665. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study of LY3074828 in Subjects With Moderate to Severe Ulcerative Colitis
Study identification
- NCT ID
- NCT02589665
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Eli Lilly and Company
- Industry
- Enrollment
- 249 participants
Conditions and interventions
Conditions
Interventions
- Mirikizumab Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 8, 2015
- Primary completion
- Dec 18, 2017
- Completion
- May 6, 2019
- Last update posted
- Jun 16, 2020
2015 – 2019
United States locations
- U.S. sites
- 11
- U.S. states
- 9
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Precision Research Institute, LLC | Chula Vista | California | 91910 | — |
| University of California - San Diego | La Jolla | California | 92093 | — |
| Inland Empire Liver Foundation | Rialto | California | 92377 | — |
| Borland Groover Clinic | Jacksonville | Florida | 32256 6004 | — |
| University of Chicago Medical Center | Chicago | Illinois | 60637 | — |
| Delta Research Partners LLC | Monroe | Louisiana | 71201 | — |
| University of Michigan | Ann Arbor | Michigan | 48109 | — |
| Minnesota Gastroenterology, P.A. | Plymouth | Minnesota | 55446 | — |
| Columbia University Medical Center | New York | New York | 10032 | — |
| Carolinas Healthcare System | Charlotte | North Carolina | 28204 | — |
| Care Access Research - Salt Lake City | Salt Lake City | Utah | 84124 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 65 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02589665, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 16, 2020 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02589665 live on ClinicalTrials.gov.